Severe, Malignant
Osteopetrosis (SMO)

Sign Up for COMPASSSM Support

Call a Case Manager at

(877) 305-7704 Monday-Friday
8:00 AM to 6:00 PM ET
Sign up online and receive a call back from a Program Coordinator within
one business day.

Personalized
Financial Support

Get Answers From a
Case Manager

ACTIMMUNE® (Interferon gamma-1b) Is FDA Approved for Patients With Severe, Malignant Osteopetrosis

ACTIMMUNE® is approved by the US Food and Drug Administration to slow the worsening of severe, malignant osteopetrosis (SMO). SMO is a genetic disorder that affects normal bone formation.

Visit ACTIMMUNE.com to learn more about the treatment of SMO.

Enroll in the COMPASSSM Program or contact Horizon Pharma for more information.